HK1145446A1 - Pharmaceutical composition for losing weight or treating hyperlipidemia - Google Patents
Pharmaceutical composition for losing weight or treating hyperlipidemiaInfo
- Publication number
- HK1145446A1 HK1145446A1 HK10111888.0A HK10111888A HK1145446A1 HK 1145446 A1 HK1145446 A1 HK 1145446A1 HK 10111888 A HK10111888 A HK 10111888A HK 1145446 A1 HK1145446 A1 HK 1145446A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical composition
- losing weight
- treating hyperlipidemia
- hyperlipidemia
- treating
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101754848A CN101756990B (en) | 2008-11-10 | 2008-11-10 | Medical composition for losing weight or treating hyperlipidemia |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1145446A1 true HK1145446A1 (en) | 2011-04-21 |
Family
ID=42488472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10111888.0A HK1145446A1 (en) | 2008-11-10 | 2010-12-20 | Pharmaceutical composition for losing weight or treating hyperlipidemia |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101756990B (en) |
HK (1) | HK1145446A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101889975A (en) * | 2010-07-27 | 2010-11-24 | 北京虹湾医药技术有限公司 | Rosuvastatin calcium sustained-release preparation and preparation method thereof |
CN103393608B (en) * | 2013-08-13 | 2015-09-16 | 杭州高成生物营养技术有限公司 | A kind of Cetilistat micropill and preparation method thereof |
CN105168158B (en) * | 2015-08-18 | 2018-08-03 | 上海韬鸿化工科技有限公司 | A kind of Rosuvastatin calcium dispersible tablet and preparation method thereof |
CN106955357B (en) * | 2017-05-22 | 2019-05-07 | 成都导飞科技有限公司 | A kind of compound orlistat composite preparation and its application for pet weight-reducing |
CN110357812A (en) * | 2019-08-03 | 2019-10-22 | 黄泳华 | The eutectic compound being made of lipase inhibitor and hydroxy-3-methylglutaryl CoA reductase inhibitor |
CN110314232A (en) * | 2019-08-03 | 2019-10-11 | 黄泳华 | The composition being made of lipase inhibitor and hydroxy-3-methylglutaryl CoA reductase inhibitor |
-
2008
- 2008-11-10 CN CN2008101754848A patent/CN101756990B/en active Active
-
2010
- 2010-12-20 HK HK10111888.0A patent/HK1145446A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101756990A (en) | 2010-06-30 |
CN101756990B (en) | 2011-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1216232A1 (en) | Controlled release pharmaceutical composition | |
IL228817A0 (en) | Pharmaceutical composition | |
HK1170490A1 (en) | Pharmaceutical composition for treating or preventing glaucoma | |
GB2454567B (en) | Anti-malarial pharmaceutical composition | |
ZA201102715B (en) | Solid pharmaceutical composition | |
IL208387A0 (en) | Pharmaceutical composition | |
HK1145446A1 (en) | Pharmaceutical composition for losing weight or treating hyperlipidemia | |
ZA201100871B (en) | Solid pharmaceutical composition | |
ZA201006224B (en) | Pharmaceutical composition | |
GB2464200B (en) | Pharmaceutical composition | |
HK1145447A1 (en) | Pharmaceutical composition for losing weight or for treating metabolic syndromes | |
HK1145445A1 (en) | Pharmaceutical composition for losing weight or for treating metabolic syndromes | |
ZA201204341B (en) | Pharmaceutical composition for treating gutaneous burns | |
HK1145399A1 (en) | Pharmaceutical composition for treating hemorrhoids | |
EP2382992A4 (en) | Pharmaceutical composition for treating obesity or diabetes | |
GB0817969D0 (en) | Pharmaceutical composition | |
EP2417972A4 (en) | Pharmaceutical composition for treating or preventing burn injuries | |
PL384259A1 (en) | Pharmaceutical composition for treating skin-diseases | |
GB0817974D0 (en) | Pharmaceutical composition | |
GB0817566D0 (en) | Pharmaceutical composition | |
TWI372054B (en) | A pharmaceutical composition for preventing or treating cardiovascular disease | |
HU0800741D0 (en) | Improved pharmaceutical composition | |
GB0808141D0 (en) | A composition for the treatment of concrete |